While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions.

Emergent stock is down >40% since my last update. I had given the EBS stock a "Buy" rating but noted that 2025 may be a ...

Johnson & Johnson said Wednesday that it is recalling five of its sunscreen products after some samples were found to contain low levels of benzene, a chemical that can cause cancer with repeated ...

Television personality Ashley, 33, and his ex partner Safiyya, 36, tragically lost their little girl when she was eight ...

The startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or ...